Nucleated red blood cells impact DNA methylation and expression analyses of cord blood hematopoietic cells by unknown
RESEARCH Open Access
Nucleated red blood cells impact DNA
methylation and expression analyses of
cord blood hematopoietic cells
Olivia M. de Goede1,2, Hamid R. Razzaghian1,3, E. Magda Price1,2,4, Meaghan J. Jones2,5, Michael S. Kobor2,5,
Wendy P. Robinson1,2* and Pascal M. Lavoie1,3*
Abstract
Background: Genome-wide DNA methylation (DNAm) studies have proven extremely useful to understand human
hematopoiesis. Due to their active DNA content, nucleated red blood cells (nRBCs) contribute to epigenetic and
transcriptomic studies derived from whole cord blood. Genomic studies of cord blood hematopoietic cells isolated
by fluorescence-activated cell sorting (FACS) may be significantly altered by heterotopic interactions with nRBCs
during conventional cell sorting.
Results: We report that cord blood T cells, and to a lesser extent monocytes and B cells, physically engage with
nRBCs during FACS. These heterotopic interactions resulted in significant cross-contamination of genome-wide
epigenetic and transcriptomic data. Formal exclusion of erythroid lineage-specific markers yielded DNAm profiles
(measured by the Illumina 450K array) of cord blood CD4 and CD8 T lymphocytes, B lymphocytes, natural killer (NK)
cells, granulocytes, monocytes, and nRBCs that were more consistent with expected hematopoietic lineage
relationships. Additionally, we identified eight highly differentially methylated CpG sites in nRBCs (false detection
rate <5 %, |Δβ| >0.50) that can be used to detect nRBC contamination of purified hematopoietic cells or to assess
the impact of nRBCs on whole cord blood DNAm profiles. Several of these erythroid markers are located in or near
genes involved in erythropoiesis (ZFPM1, HDAC4) or immune function (MAP3K14, IFIT1B), reinforcing a possible
immune regulatory role for nRBCs in early life.
Conclusions: Heterotopic interactions between erythroid cells and white blood cells can result in contaminated
cell populations if not properly excluded during cell sorting. Cord blood nRBCs have a distinct DNAm profile that
can significantly skew epigenetic studies. Our findings have major implications for the design and interpretation of
genome-wide epigenetic and transcriptomic studies using human cord blood.
Background
With the increased accessibility of high throughput
technologies for epigenetic and gene expression stud-
ies, genome-wide approaches have gained popularity
in studies of hematopoietic cell lineage relationships
[1–4]. However, although genome-wide profiling of
isolated blood cells can provide a large amount of in-
formation, data interpretation is notoriously difficult
in mixed cell populations [5–7]. To address this issue,
studies can be performed either on homogeneous cell
populations or on mixed cell samples with deconvolu-
tion algorithms applied to correct for differences in
cell composition [8, 9]. One concern with the former
approach in blood is that red blood cells (RBCs) have
been shown to engage in functional heterotopic inter-
actions with other hematopoietic cells [10–16]. If not
formally excluded using lineage markers, these interactions
could impact whole-genome studies of hematopoietic cells
sorted by fluorescence-activated cell sorting (FACS), par-
ticularly in cord blood which has a notable proportion of
nucleated RBCs (nRBCs) [17].
The proportion of nRBCs in cord blood varies consider-
ably between individuals. Typically, these cells represent
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only a few percent of the total nucleated cell count;
however, they can comprise up to 50 % of all nucle-
ated cells in some chronic hypoxic-ischemic-related
pregnancy situations [17–19]. For example, higher
nRBC counts have been observed in response to pre-
natal exposure to infection, preeclampsia, maternal obes-
ity, diabetes, and smoking [17–22]. nRBCs are generally
resistant to lysis protocols and tend to sediment in the
mononuclear cell fraction during purification by density
gradient centrifugation, further complicating the isolation
of pure hematopoietic cell populations [23]. Depending on
their proportion, the presence of nRBCs could complicate
both epigenetic and gene expression studies.
Under non-pathological conditions, DNA methylation
(DNAm) shows great biological differences with tissue
and cell type. Clustering of adult blood cells based on
their DNAm profiles is consistent with the classical
model of hematopoietic lineage relationships [6, 9, 24].
However, our initial analysis of genome-wide DNAm in
cord blood cell populations isolated by FACS suggested
significant cross-contamination between cell types. We
observed low-incidence white blood cell (WBC) hetero-
topic interactions with nRBCs that were undetected by
traditional singlet FACS gating, due to the small size of
nRBCs. Thus, to obtain pure WBC populations, we de-
veloped and implemented a stringent sorting protocol
that excludes erythroid-specific surface markers. The
DNAm profiles of cell populations obtained by our
stringent FACS method were used (1) to evaluate the
impact of nRBC contamination on the DNAm profiles
of T lymphocytes and monocytes and (2) to identify
nRBC-distinct DNAm markers to detect erythroid con-
tamination in genome-wide DNAm studies.
Results and discussion
Heterotopic cell interactions impact genome-wide
signatures of hematopoietic cells
Heterotopic cell interactions are a well-known occur-
rence that may confound cell-specific studies. To avoid
this problem, cell doublets are generally excluded during
FACS by employing forward/side scatter width singlet
gatings. Despite applying these standard criteria, we
observed small proportions of double positive events
co-expressing both T cell (CD3)- and erythroid
(CD235)-specific lineage markers. When analyzed by
flow cytometry after sorting, these double positive events
were found to be distinct cell events expressing either
erythroid or T cell markers (Fig. 1a). Examination of these
sorted events under light microscopy confirmed that they
were T cell-RBC doublets (not shown). To a lesser extent,
we also detected events positive for expression of both
erythroid (CD235) and monocyte (CD14) or B cell (CD19)
markers (not shown). These findings indicate that
heterotopic RBC-to-WBC doublets can be undetected by
FACS using conventional singlet gating.
We assessed the impact of these rare heterotopic RBC-
to-WBC interactions on genome-wide DNAm and gene
expression analyses of hematopoietic cord blood cells.
First, DNAm data from T cells, monocytes, and nRBCs
sorted without formal exclusion for an erythroid cell
lineage marker were evaluated. Unsupervised Euclidean
clustering of array-wide DNAm showed unexpected clus-
tering of nRBCs with T cells and monocytes as the most
epigenetically distinct population (Fig. 1b). When these
cell populations were compared to identify differentially
methylated (DM) sites (false detection rate (FDR) <5 %,
|Δβ| > 0.20), nRBCs versus T cells had fewer DM sites
(3538) than either nRBCs versus monocytes (12,852) or T
cells versus monocytes (18,738) (Fig. 1c). Even at their
largest-magnitude DM sites, nRBCs sorted by the stand-
ard FACS strategy often displayed DNAm values inter-
mediate to the DNAm of monocytes and T cells (Fig. 1d).
This is unusual, since exemplar cell-specific DM sites are
typically either fully methylated (β > 0.80) or unmethylated
(β < 0.20), with comparison cells exhibiting opposing levels
of DNAm [6, 25]. Whole-genome expression data were
also compared between naïve CD4 T cells sorted by the
standard FACS method and naïve CD4 T cells sorted by
the stringent FACS method. We observed a high expres-
sion of hemoglobin genes in T cells sorted by the standard
protocol, but not in T cells sorted by the stringent proto-
col (Fig. 2). Finally, to assess whether this problem also ap-
plies to other studies, we examined gene expression
datasets of hematopoietic cells publicly available in the
Gene Expression Omnibus. Expression of hemoglobin
genes was high in the majority of cord blood hematopoietic
cell datasets that we examined, indicating widespread
contamination of previously published datasets (Additional
file 1: Figure S2). In contrast, increased hemoglobin gene
expression was not observed in hematopoietic cells col-
lected from adult blood. Together, these findings suggest
that heterotopic cell interactions, though a rare occur-
rence, significantly impact genome-wide molecular signa-
tures of hematopoietic cells from cord blood.
Revised DNAm profiles of hematopoietic cells obtained
by a more stringent cell sorting strategy
When employing a stringent sorting strategy that for-
mally excludes RBCs, the DNAm relationships between
cord blood T cells, monocytes, and nRBCs were more
consistent with previous hematopoietic lineage studies
[2, 26–29]. Unsupervised Euclidean clustering by array-
wide DNAm showed that nRBCs were epigenetically
closer to the myeloid lineage (monocytes) than to the
lymphoid lineage (T cells) following this stringent sorting
approach (Fig. 3a). Additionally, each hematopoietic popu-
lation was more epigenetically distinct, as reflected by
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both principal component analysis (Additional file 1:
Figure S3) and the greater number of DM sites for
each cell type comparison following stringent sorting
(24,263 for nRBCs versus T cells; 12,980 for nRBCs
versus monocytes; 19,278 for T cells versus mono-
cytes; Fig. 3b) compared to standard sorting (Fig. 1c).
CD4 T cells and nRBCs sorted by the stringent proto-
col showed a greater number of cell-specific DM sites
than whole (CD3+) T cells and nRBCs sorted by the
standard protocol (Table 1). In contrast, monocytes
sorted by the stringent protocol showed fewer DM
sites, likely due to the DNAm profile of nRBCs be-
coming more similar to monocytes after stringent cell
sorting (Fig. 3a).
Top DM sites for each cell type (FDR <5 %, |Δβ| > 0.20)
were then compared between the two sorting protocols.
For T cells, the majority of DM sites (>98 %) discovered
by the standard method overlapped with the DM sites
identified by the stringent protocol (Fig. 3c). A notable
percentage (47 %) of monocyte DM sites found by the
standard protocol were also discovered by the stringent
protocol (Fig. 3d). For nRBCs, the DM sites identified by
the two protocols showed the least overlap (36 %), with
the stringent protocol identifying far more nRBC DM sites
than the standard protocol (8982 versus 2338) (Fig. 3e).
Of the 8982 stringent nRBC DM sites, six were located
in hemoglobin genes we found to be highly expressed
in cord blood WBCs sorted by a standard protocol (and
Fig. 1 DNAm profiles of cord blood cells isolated by the standard FACS strategy. a A CD14-/CD19-/CD3+/CD235+ population isolated by
FACS (left panel) is revealed to be T cell/RBC doublets by flow cytometry, which identifies two distinct cell types after sorting (right panel).
b Unsupervised Euclidean clustering of genome-wide DNAm (440,315 CpG sites) between whole T cells (CD3T), nRBCs, and monocytes (Mo); numbers
in the sample labels indicate different cord blood donors. c Number of large magnitude DM sites (FDR <5 %, |Δβ| >0.20) between nRBCs and T cells,
nRBCs and monocytes, and T cells and monocytes sorted using a standard approach. d DNAm heatmap of nRBCs, T cells, and monocytes at top nRBC
DM sites identified by the standard sorting protocol (FDR <5 %, |Δβ| >0.30; 457 CpG sites)
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thus presumed to be contaminated with RBCs) (Fig. 2;
Additional file 1: Table S2). These genes were also
found to be highly expressed in publicly available data-
sets of cord blood WBCs, again indicating widespread
erythroid contamination (Additional file 1: Figure S2).
The DNAm differences at these loci were striking, with
the mean nRBC DNAm up to 43 percentage points less
than the mean DNAm for all WBCs. Several of these
CpG sites are located in either the body of the associ-
ated hemoglobin gene or within 300 bases upstream of
its transcriptional start site and may be associated with
erythroid-specific gene expression.
The top DM sites from the stringent protocol repre-
sent sites with the strongest cell-specific DNAm patterns
(8982 nRBC DM sites, 12,014 CD4 T cell DM sites, and
5940 monocyte DM sites). Thus, we used these sites to
confirm heterotopic cell interactions in the standard
protocol. The distribution of DNAm values for each cell
type-by-protocol combination shows a defined shift in
DNAm of the nRBC population between sorting methods
(Fig. 4). When sorted by the standard method, nRBC
DNAm was more similar to the DNAm patterns of T
cells. The exclusion of other hematopoietic lineages in
the stringent sorting of nRBCs dramatically decreased
nRBC DNAm, suggesting a cleaner population of these
cells. In contrast, the impact of sorting protocol on
DNAm profiles of monocytes and T cells was modest.
To further evaluate how sorting strategy affected cell
type epigenetic profiles, we looked at discordant sites:
sites which were DM in one sorting protocol, but not in
the other. In nRBCs, differential DNAm unique to the
standard protocol was observed at 1505 sites, while 8149
sites were uniquely DM in the stringent protocol (Fig. 3e).
An example nRBC-discordant site is provided in Fig. 5a: a
CpG site in BCL11B shows nRBC DNAm trending toward
T cell levels in the standard FACS protocol, but exhibiting
DNAm similar to other non-T cells in the stringent FACS
protocol. In contrast to nRBCs, monocytes sorted by the
stringent protocol had few DM sites that were not also
identified in the standard protocol (Fig. 3d). Unlike nRBC-
discordant sites, there appeared to be multiple reasons for
monocyte-discordant sites. At some of these sites, abso-
lute DNAm in monocytes did not change significantly
between the two sorting protocols, but the change in
nRBC DNAm with stringent sorting impacted the detec-
tion of differential DNAm when compared to monocytes
(Fig. 5b). For other sites, DNAm differences were noted
between protocols for all three cell types and may be at-
tributable to technical noise or genetic differences be-
tween the different set of subjects for each sorting
method. In fact, a few of the discordant sites were
clearly “epipolymorphisms”, in which changes in
DNAm levels were associated with individuals rather
than cell types; this resulted in highly variable DNAm
patterns within a cell type (Fig. 5c) [30].
Comparing the cell-specific DM sites discovered by each
sorting protocol further supports our hypothesis of het-
erotopic cell doublet contamination in the standard proto-
col. This contamination appears to have a much greater
effect on nRBC DNAm than on T cell or monocyte
DNAm. We attribute this to the relatively low proportion
(~5–10 %) of RBCs that was nucleated in our samples
Fig. 2 Transcriptomic profiles of naïve CD4 T cells indicate erythroid contamination when sorting by the standard, but not the stringent, FACS
strategy. Log2(expression) of 20,876 gene probes in naïve CD4 T cells sorted by either a standard (no erythroid exclusion) or stringent (exclusion
of erythroid-specific surface markers) FACS strategy. Top differentially expressed genes between these T cell populations were hemoglobin genes and
ALAS2, a gene involved in heme synthesis, all of which exhibit increased expression in T cells sorted without formal exclusion of erythroid lineage markers
de Goede et al. Clinical Epigenetics  (2015) 7:95 Page 4 of 11
Fig. 3 DNAm profiles of cord blood cells isolated using the stringent FACS strategy. a Unsupervised Euclidean clustering of genome-wide DNAm
(440,315 CpG sites) in CD4 and CD8 T cells (CD4T and CD8T, respectively), monocytes (Mo), and nRBCs isolated by a stringent FACS protocol; letters
in the sample labels indicate different cord blood donors. b Number of large magnitude DM sites (FDR <5 %, |Δβ| >0.20) between nRBCs
and CD4 T cells, nRBCs and monocytes, and CD4 T cells and monocytes sorted using a stringent approach. c–e Overlap of cell-specific DM
sites (FDR <5 %, |Δβ| >0.20) identified in the standard versus stringent sorting protocols for c T cells, d monocytes, and e nRBCs. Note that
the stringent protocol identified a large number of additional DM sites in T cells and that the nRBC DM sites found by the two sorting
protocols showed more differences than similarities
Table 1 Number of cell-specific DM CpG sites (FDR <5 %) following the standard and stringent FACS strategies












NA 61,405 197,237 41,451 80,600 39,284 111,965
0.05 38,295 144,949 32,558 32,846 23,060 50,621
0.10 11,848 63,099 22,829 14,864 10,868 27,420
0.20 2338 8982 11,855 5940 2602 12,014
0.30 457 2628 6486 3162 879 5474
0.40 17 648 3520 1757 292 2600
0.50 0 41 1884 878 48 1268
0.60 0 1 908 319 2 553
0.70 0 0 255 51 0 158
0.80 0 0 3 1 0 12
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(Fig. 6). The impact of heterotopic contamination by
WBCs on the DNAm profile of sorted nRBCs is more ob-
vious than the reverse, since all WBCs are nucleated.
However, since the proportion of nRBCs can be as high as
50 % of all nucleated cells in cord blood [17–19], we ex-
pect that cross-contamination during FACS can have a
major impact on the DNAm profile of sorted WBCs in a
subset of cases.
Erythroid-specific DM sites
To provide a way to evaluate how DNAm profiles are im-
pacted by a mixture of blood cells, we defined erythroid
lineage-specific DNAm markers. DNAm of B cells, CD4
and CD8 T cells, granulocytes, monocytes, and natural
kills (NK) cells sorted using the stringent FACS strategy
were compared to stringently sorted nRBCs. For each
WBC population, over 210,000 of the 440,315 CpG sites
analyzed showed statistically significantly different
DNAm from nRBCs (FDR <5 %). Eight of these DM
sites, termed erythroid DNAm markers, were selected
based on a cell type average difference in DNAm >0.50
between nRBCs and every other cell type (Table 2;
Additional file 1: Figure S4). We did not consider gene
function in marker selection, as the intention is to use
these erythroid DNAm markers to quickly detect nRBC
contamination in cell samples using targeted methyla-
tion assays, such as pyrosequencing. At all eight CpG
sites, nRBCs are hypomethylated compared to WBCs;
thus, if a sample is significantly contaminated, DNAm
should be notably lower than reference WBC levels
(Additional file 1: Figure S4).
Some of these erythroid DNAm markers are associ-
ated with genes that have known erythropoietic
function, such as ZFPM1 and HDAC4 (Table 2). The
zinc finger protein ZFPM1 acts as a cofactor for
GATA-1, a key transcription factor in erythroid differ-
entiation [31, 32]. Histone deacetylase 4 (HDAC4) dir-
ectly associates with GATA-1 and its expression is
specifically reduced during erythroid maturation,
likely being localized to the nucleus [33]. HDAC4 may
be involved in the enucleation process of nRBCs: histone
deacetylation by HDACs is essential for heterochromatin
formation, and condensed chromatin is a main require-
ment for enucleation and terminal erythroid differenti-
ation [34]. Interestingly, other erythroid DNAm markers
are near genes involved in immune functions, such as
MAP3K14 and IFIT1B, consistent with the idea that
nRBCs have an immunoregulatory role in early life [13].
MAP3K14 induces NF-kappa-B signaling, a major in-
flammatory response pathway [35]. IFIT1 is typically
silent in most cells, but becomes highly expressed in
response to interferons, viral infection, and certain
molecular patterns, with IFIT proteins having antiviral
effects through binding and modulation of host and
viral proteins and RNA [36]. As these erythroid DNAm
marker sites are located largely in enhancer regions, re-
duced DNAm in nRBCs may reflect either specific upreg-
ulation of these genes in erythroid cells or a more
primitive permissive state that is actively shut off in differ-
entiation of other cell types.
Although these erythroid DNAm markers are the top
nRBC DM sites, they display notable inter-individual
variability in nRBC DNAm, with β value standard devi-
ations ranging from 0.048 to 0.091. We hypothesize
that this variability in DNAm may be related to import-
ant inter-individual differences in nRBC function or
maturation, based on the negative Pearson correlation
Fig. 4 DNAm changes in nRBCs, T cells, and monocytes with FACS strategy at their top DM sites. Density distributions of DNAm (β values) at DM
CpG sites (FDR <5 %, |Δβ| >0.20) for each of the three cell types, comparing the two sorting methods. DM sites were identified using data from
samples sorted by the stringent protocol only. The β distributions suggest that nRBCs are most affected by the sorting protocol. a 8982 nRBC DM
sites. b 12,014 CD4 T cell DM sites. c 5940 monocyte DM sites
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we observed between array-wide median nRBC DNAm
and nRBC proportion (r = −0.86, p = 0.013) (Additional
file 1: Figure S5A). Linear modeling identified 5935
CpG sites significantly associated (FDR <5 %) with
nRBC proportion, including three of the eight CpG
sites identified as erythroid DNAm markers (Additional
Fig. 5 Selected discordant DM sites between the standard and stringent FACS protocols. At these discordant CpG sites, a given cell type is DM
only in one protocol, but not the other. a An example CpG site illustrating contamination of nRBCs with T cells after sorting by standard FACS
methods. The nRBCs trend toward T cell DNAm in the standard method, but are hypermethylated (like all other non-T cells) after sorting by the
stringent method. b, c Examples of discordant sites in monocytes due to heterotopic cell interactions (b) or epipolymorphisms (c). In b, absolute
DNAm in monocytes does not change significantly between the two protocols, but the change in nRBC DNAm with FACS protocol influences
whether monocytes are identified as DM. In c, DNAm at the CpG site is likely attributable to genetic variation. This was confirmed by comparing
DNAm plotted by cell type (left boxplots) to plotting by individual (right boxplots). DNAm in each individual shows one of three distinct levels of
DNAm, presumably depending on the individual’s genotype at the site influencing DNAm
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file 1: Figure S5B–C). These results suggest that DNAm
changes in cord blood nRBCs occur dynamically as a
function of nRBC production and maturation, thereby re-
vealing an additional level of functional complexity to
consider in whole-genome DNAm analyses of nRBCs.
Conclusions
While nRBCs are generally absent or rare in adult blood,
they are commonly present in low proportion in cord
blood, with a higher nRBC count associated with a var-
iety of maternal and fetal health factors [17, 19–22]. Our
Fig. 6 Erythroid-WBC interactions during FACS affect DNAm based on the proportion of nRBCs. As illustrated, only a fraction of erythroid cells are
nucleated; therefore, contaminating nRBCs contribute less DNA than contaminating WBCs. As a consequence, heterotopic cell interactions during
FACS have greater weight on the DNAm profiles of erythroid cells than of WBCs (in this figure, T cells), which are all nucleated. This illustrates how the
relative impact of cross-contamination during FACS on DNAm can be much greater for nRBCs than for WBCs. However, WBC DNAm can
also be strongly affected in a subset of cases where overall nRBC proportion is high
Table 2 Top eight CpG sites with nRBC-distinct DNAm from white blood cells in cord blood
450K array CpG identifier CpG location: chromosome,
closest gene
Location in gene Mean nRBC β
(min., max.)
Mean non-erythroid cell β
(min., max.)
cg05012676 16, ZFPM1 Intron 0.421 0.937
(0.298, 0.508) (0.896, 0.963)
cg06768361 12, TESC Intron; enhancera 0.336 0.924
(0.211, 0.426) (0.825, 0.978)
cg10018933 2, HDAC4 Intron; enhancerb 0.410 0.922
(0.346, 0.468) (0.890, 0.953)
cg15974642 10, IFIT1B TSS200 0.362 0.939
(0.234, 0.475) (0.904, 0.957)
cg18168751 4, IDUA TSS1500; enhancera 0.435 0.951
(0.356, 0.556) (0.924, 0.969)
cg20555305 8, CPSF1 Intron 0.369 0.878
(0.277, 0.481) (0.823, 0.917)
cg25105522 17, MAP3K14 Intron; enhancerb 0.224 0.872
(0.126, 0.300) (0.750, 0.962)
cg26876834 16, SNORA64 & RPS2 SNORA64: TSS1500 0.369 0.890
RPS2: Intron (0.227, 0.440) (0.839, 0.938)
aBased on UCSC Genome Browser: ENCODE enhancer- and promoter-associated histone mark (H3K4Me1) in the K562 cell line
bBased on Illumina 450K array annotation
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data show that nRBCs have a distinct DNAm profile,
with an association between nRBC DNAm and overall
nRBC proportion in cord blood (Table 1; Figs. 3a–b
and 4; Additional file 1: Figure S5). The complex
DNAm profile of nRBCs has implications for epigen-
etic studies of whole cord blood and mononuclear
cells, in which nRBCs have a demonstrable effect on
DNAm (M.J.J. et al., manuscript in preparation). Des-
pite the variability in nRBC DNAm at our identified
erythroid DNAm markers, we believe that these sites
will be sufficient to detect erythroid cells due to the
low variation within all WBCs at these sites, as well
as the large magnitude of DNAm difference between
nRBCs and other cell types.
Heterotopic interactions between erythroid cells and
WBCs are likely biologically meaningful events, since
RBCs have immune functions that require cell-to-cell
contact with WBCs. These include modulation of T
lymphocyte and neutrophil survival [10, 11, 14] and im-
munosuppression in T and B lymphocytes and dendritic
cells [12, 13, 16]. Additionally, RBCs adhere to macro-
phages to form erythroblastic islands during both fetal
and adult RBC maturation [37]. Our data highlight the
importance of formally excluding these interactions in
lineage studies of cord blood hematopoietic cells using
flow cytometry. This has major ramifications for the de-
sign of epigenetic, transcriptomic, and functional studies
of cord blood cells.
Availability of supporting data
The data set supporting the results of this article is avail-




Ethics, consent and permissions
Ethics approval for this study was obtained from the
University of British Columbia Children’s & Women’s
Research Ethics Board (certificate numbers H07-02681
and H04-70488). Written, informed parental consent to
participate was obtained. Individual patient data is not
reported.
Cell collection
Cord blood was collected from neonates delivered by
elective cesarean section in the absence of labor at the
Children’s & Women’s Health Centre of BC (Vancouver,
Canada).
Hematopoietic cell purification and sorting is de-
scribed in the Additional file 1: Supplemental Methods.
Two sorting protocols were compared, which are re-
ferred to as the “standard” and “stringent” protocols.
The stringent method includes additional negative gating
steps, mainly for erythroid lineage-specific cell surface
protein markers (Additional file 1: Figure S1; Additional
file 1: Table S1). For DNAm studies, cells were sorted
from a total of 12 subjects: whole (CD3+) T cells, mono-
cytes, and nRBCs were collected from five individuals by
the standard sorting method; B cells, CD4 T cells, CD8
T cells, granulocytes, monocytes, NK cells, and nRBCs
were collected from seven individuals by the stringent
sorting method. For genome-wide gene expression ana-
lysis, naïve CD4 T cells were sorted from 12 additional
subjects. Transcriptomic profiling is described in the
Additional file 1: Supplemental Methods.
DNAm measurement and data normalization
DNA was extracted from isolated cell populations using
standard protocols and purified with the DNeasy Blood and
Tissue kit (QIAGEN, MD, USA). DNA was bisulfite-
converted using the EZ DNA Methylation Kit (Zymo
Research, CA, USA) before amplification and hybridization
to the Illumina Infinium HumanMethylation450 BeadChip
(450K array) following manufacturer’s protocols (Illumina
Inc., CA, USA). With a HiScan reader (Illumina), 450 K
chips were scanned.
Raw intensity data (GSE68456) were background nor-
malized in GenomeStudio (Illumina). Quality control
was performed using the 835 control probes included in
the array. The intensity data were then exported from
GenomeStudio and converted into M values using the
lumi package [38] in R software [39]. Sample identity and
quality were evaluated as described in the Additional file
1: Supplemental Methods, and one NK cell sample was re-
moved as an outlier. The 450K array targets 485,577
DNAm sites, but probe filtering was performed as de-
scribed in the Additional file 1: Supplemental Methods to
produce a final dataset of 440,315 sites [40]. Red-green
color bias was corrected for using the lumi package, and
the data were normalized with subset within-array quan-
tile normalization [38, 41].
Analysis of hematopoietic cell lineage DNAm
relationships
Since the stringent FACS strategy was designed based on
results from the standard FACS strategy, sample collec-
tion and 450K array runs for cells collected by these two
protocols were done separately. To avoid confounding
by batch effects, DNAm analyses were also performed
separately for the data from each FACS protocol. Our
analytic approach was to compare cell types sorted by
the same FACS protocol to each other and then to
evaluate whether a given cell type’s epigenetic relation-
ship with the other cell types changed between FACS
methods. To eliminate DNAm differences that can arise
due to genetic effects, comparisons were made between
cell types derived from the same set of individuals.
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For the standard sorting method, DNAm data were
available for nRBCs, monocytes, and T cells from five indi-
viduals at 440,315 sites after pre-processing. Unsupervised
Euclidean clustering of the samples based on DNAm β
values was performed as an initial global analysis step. Dif-
ferential DNAm between each blood cell pairing was
tested by linear modeling through the R package limma
[42]. Surrogate variable (SV) analysis using the R pack-
age sva [43] was performed to account for unwanted
variability in the linear modeling. SVs were used as co-
variates in the model, with cell type as the main effect.
Resulting p values were adjusted for multiple compari-
sons by the Benjamini and Hochberg [44] FDR method,
and we limited statistically significant sites to those that
passed an FDR <5 %. SV-corrected data was used for
DNAm-based filtering of the statistically significant
sites. At each site, a between-group difference in DNA
methylation (Δβ) was calculated by subtracting mean
DNAm for one cell type from the other. Differentially
methylated (DM) sites were considered as those having
both an FDR <5 % and |Δβ| >0.20.
For the stringent sorting method, DNAm data were
available for B cells, CD4 T cells, CD8 T cells, granulo-
cytes, monocytes, NK cells, and nRBCs from seven indi-
viduals at 440,315 CpG sites after pre-processing. To
analyze the data in a comparable way to the standard
FACS protocol, only CD4 T cells, monocytes, and nRBCs
were considered. The DNAm profiles of these cell popu-
lations were analyzed as described for the standard sort-
ing protocol.
To identify DNAm markers specific to nRBCs, data
from the stringent sorting method for all seven cell types
were used. DM sites between nRBCs and every other cell
type were detected by linear modeling with nRBCs as the
reference cell type and SVs included as covariates. Signifi-
cantly, DM sites were defined as those with a FDR <5 %
and a |Δβ| >0.50. Finally, to evaluate the relationship be-
tween nRBC proportion in whole cord blood and DNAm
of nRBCs, the SV-corrected M values for the seven nRBC
samples collected by stringent FACS methods were used.
Linear modeling was performed with nRBC proportion
(as measured by number of nRBCs/100 WBCs in whole
blood) as the main effect and no covariates.
Additional file
Additional file 1: Supplemental Methods and Data. This contains
Supplemental Methods, Supplemental Tables 1 and 2 and Supplemental
Figures 1-5.
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